Global Oligonucleotide Synthesis Market size is expected to register a CAGR of 13.19% during the forecast period of 2019 to 2025.
Oligonucleotides are little fragments of nucleic acids that are produced through enzymatic chemistry and genetic engineering. The market over the review period is also expected to earn substantial valuation. The chemical synthesis of the nucleic acids with definite chemical structures is known as oligonucleotide synthesis. Its ability to produce results regarding customized nucleotides rapidly through inexpensive methods is making it choicest preference for a lot of research laboratories that are spending heavily in developing biotechnologies.
Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/2337
Ventures and investments from big companies in the oligonucleotide synthesis market can prove beneficial in the coming years. Gene study can provide much-needed traction, and the market can witness substantial rise during the forecast period. But the cost associated with it can be a major factor, and lack of adept hands can be a market deterrent.
Competitive Landscape:
Prominent players functioning in the oligonucleotide synthesis market, as described by MRFR, are GE Healthcare (U.S.), Integrated DNA Technologies, Inc (U.S), Eurogentec S.A (Belgium), Sigma-Aldrich Corporation (U.S.), Bioautomation Corporation (U.S.), Agilent Technologies Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eurofins Genomics (Germany), L.G.C Biosearch Technologies (U.S.), Nitto Denko Avecia Inc. (Japan), and others.
- Scientists at the University of California, Berkeley, and Lawrence Berkeley National Laboratory developed an effective way to perform DNA synthesis without toxic chemicals, and its results are more accurate than previous techniques. This could lead to the development of DNA printers.
Oligonucleotide Synthesis Market Segmentation:
MRFR, for a better understanding of the oligonucleotide synthesis market, segmented the market by product type, application, and end-users.
Global Oligonucleotide Market, by Product
- Oligonucleotide
- Column-based oligos
- Array-based oligos
- Reagents
- Equipment
Global Oligonucleotide Market, by Type
- Custom Oligos
- Predesigned Oligos
Global Oligonucleotide Market, by Application
- Therapeutic Applications
- Diagnostics
- RNAi
- Nucleic Acid Aptamers
- DNA/Antisense Oligonucleotides
- Immunotherapy
- Research
- PCR
- QPCR/RTQPCR
- Sequencing
- Gene Synthesis
- Others
Global Oligonucleotide Market, by End User
- Hospitals
- Specialty Clinics
- Research Institutes
- Diagnostic Centers
- Others
Browse Complete Premium Research Details@ https://www.marketresearchfuture.com/reports/oligonucleotide-synthesis-market-2337
LIST OF TABLES
TABLE 1 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SYNOPSIS, 2019–2025
TABLE 2 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ESTIMATES & FORECAST, 2019–2025 (USD MILLION)
TABLE 3 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2019–2025 (USD MILLION)
TABLE 4 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2019–2025 (USD MILLION)
TABLE 5 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2019–2025 (USD MILLION)
TABLE 6 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2019–2025 (USD MILLION)
TABLE 7 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2019–2025 (USD MILLION)
TABLE 8 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY TYPE, 2019–2025 (USD MILLION)
Continued…
Oligonucleotide Market Regional Analysis:
Region-specific segmentation of the oligonucleotide synthesis market, as discussed in the MRFR report, includes North America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The rise of North America can be attributed to the constant search for better treatment. The robust healthcare structure and the infrastructure of the research centers are quite indicative of that. Regional endeavor for such things is getting mostly driven by chronic diseases such as cancer and diabetes. Governments and private investors are equally funding for innovation in the sector, and it can take the regional market further ahead.
Europe is getting driven by the same intents like that of North America and is getting amply backed by research centers and government initiatives. Funding for the regional market is not a big problem as many pharmaceutical companies from the region are investing substantially in understanding the gene sequence to develop better drugs. The APAC region is expected to rise significantly as many of the global titans are looking at the region as a possible investment opportunity. Infrastructural benefits and low cost of resources are some alluring factors that are controlling the market.
Ask for an any Support or Discount@ https://www.marketresearchfuture.com/enquiry/2337
The desired oligonucleotide requires a perfect oligonucleotide chain which can easily be made in laboratories. The completion of the chain sees a release from the solid phase to the solution, deprotected, and collected. MRFR in their recent report on the oligonucleotide synthesis market distinctly studied segments with their proper valuation both value-wise and volume-wise to understand the market comprehensively. Factors that can impact the market in the coming years have also been included for a critical overview of the oligonucleotide synthesis market.
Contact:
Market Research Future
Office No. 524/528, Amanora Chambers
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
+1 646 845 9312
